06:26 AM EDT, 04/02/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday it doesn't have any affiliation with Hims & Hers Health ( HIMS ) , adding that its weight-loss drug Zepbound, or tirzepatide, can be prescribed by "any licensed healthcare professional."

Hims & Hers earlier said it was expanding its weight-loss products on its telehealth platform to include generic liraglutide and branded tirzepatide.

Hims & Hers shares were down 4.9% in recent premarket activity Wednesday, while Lilly fell 0.3%.